Literature DB >> 8044722

Diagnosis and management of heart failure. Canadian Cardiovascular Society.

D E Johnstone1, A Abdulla, J M Arnold, V Bernstein, M Bourassa, J Brophy, R Davies, M Gardner, R Hoeschen, L Mickleborough.   

Abstract

Many of the recommendations presented in this consensus report are summarized in Figure 2. All patients with known or suspected heart failure should undergo a detailed history and physical examination. Other causes for the symptoms and/or clinical signs indicative of heart failure should be excluded. Routine biochemical tests, as well as a standard chest x-ray and ECG, should be performed on all patients with heart failure. Precipitating or aggravating causes of heart failure should be eliminated. Patients with potentially surgically correctable lesions, such as constrictive pericarditis, valvular disease or left ventricular aneurysm, should be referred for cardiological evaluation and the appropriate surgery. Patients with ischemic induced heart failure should be assessed for possible revascularization by either angioplasty or bypass surgery. Pending clinical findings and the degree of systolic or diastolic dysfunction present, determined by noninvasive tests, the panel made recommendations concerning the choice of various therapeutic agents. These clinical guidelines have been developed for practising physicians who manage patients with heart failure. The process by which consensus recommendations were developed by the Canadian Cardiovascular Society was based on the principle that guidelines have the best chance of succeeding if they are developed by those who will be using them. Strategies that ensure physicians are aware of the current guidelines, and that their implementation leads to measurable improvement in the diagnosis and management of patients with heart failure must be developed. Consensus reports represent an ongoing process which is subject to revision when further conclusive evidence is obtained by ongoing and future clinical trials.

Entities:  

Mesh:

Year:  1994        PMID: 8044722

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  16 in total

1.  Congestive heart failure: what can we offer our patients?

Authors:  W J Kostuk
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 2.  Community management of heart failure.

Authors:  R S McKelvie
Journal:  Can Fam Physician       Date:  1998-12       Impact factor: 3.275

3.  Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.

Authors:  E F Philbin
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

Review 4.  Beta-blockers for congestive heart failure: what is the current consensus?

Authors:  R T Tsuyuki; F A McAlister; K K Teo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

5.  Computerized practice guidelines for heart failure management: the HeartMan system.

Authors:  A Margolis; B E Bray; E M Gilbert; H R Warner
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1995

Review 6.  Underutilisation of ACE inhibitors in patients with congestive heart failure.

Authors:  T J Bungard; F A McAlister; J A Johnson; R T Tsuyuki
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Comprehensive multidisciplinary programs for the management of patients with congestive heart failure.

Authors:  E F Philbin
Journal:  J Gen Intern Med       Date:  1999-02       Impact factor: 5.128

Review 8.  Thiamin deficiency and heart failure: the current knowledge and gaps in literature.

Authors:  Mavra Ahmed; Parastoo Azizi-Namini; Andrew T Yan; Mary Keith
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

9.  Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.

Authors:  Ozlem Elkiran; Ayse Sandikkaya; Gulendam Kocak; Cemsit Karakurt; Cagatay Taskapan; Saim Yologlu
Journal:  Pediatr Cardiol       Date:  2013-03-13       Impact factor: 1.655

10.  Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology.

Authors:  Amee Shah; Angela M Feraco; Cynthia Harmon; Theresa Tacy; Jeffrey R Fineman; Harold S Bernstein
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.